%20-%20w016.jpg?width=1200&height=675&name=04_Featured_Live_Image%20(1200%C3%97675)%20-%20w016.jpg "04_Featured_Live_Image (1200×675) - w016")
DuplexSeq™ Bioinformatics: From Sequencing to Insight with the New Scantox DuplexSeq Mutagenesis App
DuplexSeq™ results are only as actionable as the bioinformatics pipeline behind them. As part of the DuplexSeq acquisition, Scantox has upgraded that pipeline, maintaining the same scientific rigor and analytical processes while transitioning to a new platform built for scalability, reproducibility, and a better in-house user experience.
Join Matt Tate, PhD of Scantox, Clint Valentine of Fulcrum Genomics, and Kyle Giffin of LatchBio for DuplexSeq Bioinformatics: From Sequencing to Insight with the New Scantox DuplexSeq Mutagenesis App on May 21, 2026 | 12:00 PM EDT / 9:00 AM PDT, followed by a Q&A session.
This session provides a structured overview of the Scantox DuplexSeq Mutagenesis App and the upgraded bioinformatics infrastructure supporting it. Matt Tate will share the strategic rationale for the upgrade, including Scantox’s focus on preserving scientific rigor while improving usability, scalability, and support for increasing demand in nonclinical genomics safety. Clint will discuss how Fulcrum Genomics approached the rebuild, covering the methodology behind the transition and the testing processes used to ensure data outcomes remain exactly as expected. Kyle will then introduce the LatchBio platform, covering the security, scalability, and compliance capabilities it brings before walking through the app in a live demonstration. The session closes with a look at how Scantox is approaching continued development and extensibility of the Scantox DuplexSeq Mutagenesis App.
Key Learning Objectives
- Understand why Scantox prioritized the DuplexSeq bioinformatics upgrade and what it delivers for in-house users.
- Learn how Fulcrum Genomics approached the rebuild and how data outcomes were validated.
- Review the security, scalability, and compliance capabilities of the LatchBio platform.
- See the Scantox DuplexSeq Mutagenesis App in a live walkthrough.
- Discover how Scantox is approaching continued development and extensibility.
Who Should Attend
- Research scientists and genetic toxicologists running DuplexSeq in-house who are responsible for data processing and interpretation.
- Computational biologists and bioinformatics leads evaluating pipeline options for NGS-based mutagenicity assays.
- Lab heads and program managers overseeing DuplexSeq scale-up or kit adoption decisions.